Full-Time

Medical Director

Oncology

Updated on 5/22/2024

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulation therapies for diseases

Biotechnology

Senior, Expert

Menlo Park, CA, USA

Requirements
  • MD required
  • Board eligible or certified in oncology/hematology
  • 2+ years' experience in a pharmaceutical environment
  • Relevant clinical research experience in academic and industry settings
Responsibilities
  • Act as a clinical expert for both internal Company team members and external contacts related to the assigned therapeutic programs
  • Provide clinical and scientific leadership including training and ongoing input to members of the development and product core teams on issues related to the therapeutic field
  • Provide medical oversight for the company's operational staff, CROs, and clinical trial sites in areas related to the oncology programs
  • Design the clinical development plan for indications relevant to assigned molecule programs and support the assessment of the development plans through the cross-functional product core team
  • Design, develop, and implement clinical studies for the applicable drug candidate, from Phase I through Phase III
  • Establish relationships with external experts in the scientific oncology areas, including principal investigators and opinion leaders, to facilitate scientific excellence in clinical trial research
  • Establish and approve scientific methods for the design and implementation of applicable clinical protocols, data collection systems, and final reports
  • Participate in the writing and review of clinical protocols, investigator brochures, clinical study reports, publications, and other documents
  • Deliver timely and high-quality clinical data
  • Provide medical oversight and safety monitoring for ongoing clinical trials including participation in SAE reporting and serving on the safety committee
  • Participate in appropriate regulatory discussion and activities, including the filing of IND’s, CTXs, NDA/MAAs, throughout the development cycle
  • Participate in clinical study report conceptualization, development and writing for global regulatory submissions

At Corcept Therapeutics, we specialize in pioneering selective glucocorticoid receptor antagonists. Our focused efforts extend to over 30 active studies aimed at addressing the detrimental impacts of excess cortisol in endocrine, metabolic, oncologic, and psychiatric conditions. We are dedicated not only to advancing medical science but also to prioritizing the well-being of our team, ensuring a collaborative and supportive work environment that fosters innovation and professional growth.

Company Stage

IPO

Total Funding

$119.1M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

13%

1 year growth

24%

2 year growth

46%